Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Scott L. Charland"'
Autor:
Scott L. Charland, Daniel C. Malone
Epidemiological data suggests for every 1% reduction in LDL-C there is a corresponding 1-1.5% reduction in cardiovascular events (CVEs). Additionally, for every 2-3% increase in HDL-C there is a reduction in CVEs by 2-4% that is independent of LDL-C.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6180fac5d07291b751dc46328a199279
Autor:
Amy M. Sainski-Nguyen, Susan Boklage, Cody J. Olsen, Diana I. Brixner, Brandon K. Bellows, Scott L. Charland, Matt Mitchell
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 23:926-934
While statins are safe and efficacious, some patients may experience statin intolerance or treatment-limiting adverse events. Identifying patients with statin intolerance may allow optimal management of cardiovascular event risk through other strateg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7d9da343e8cf4c67159877e55fb1b89
https://doi.org/10.18553/jmcp.2017.23.9.926
https://doi.org/10.18553/jmcp.2017.23.9.926
Autor:
Scott L. Charland, Eric J. Stanek, Scott T. Weiss, Sze Man Tse, Augusto A. Litonjua, Seth Goldfarb, Vivian Herrera, Ann Chen Wu
Publikováno v:
Current Medical Research and Opinion. 30:685-693
OBJECTIVE: Statins are hypothesized to have beneficial effects in asthma management through their pleiotropic anti-inflammatory effects. Several studies have examined this relationship, but have yielded conflicting results. This study investigates th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d5ddd2e0f2c4f449ab587c1d793fb69
https://doi.org/10.1185/03007995.2013.865599
https://doi.org/10.1185/03007995.2013.865599
Publikováno v:
Current Medical Research and Opinion. 23:553-563
Current prevention guidelines support efforts to achieve optimal high-density lipoprotein (HDL-C) and triglyceride (TG) values, in addition to low-density lipoprotein (LDL-C) in order to reduce cardiovascular (CV) events. The study objective was to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2561ad5c196b9aa9852711a4685d170c
https://doi.org/10.1185/030079906x167660
https://doi.org/10.1185/030079906x167660
Autor:
John Corbelli, Chaitanya Sarawate, Mark J. Cziraky, Scott L. Charland, Vincent J. Willey, Eric J. Stanek
Publikováno v:
Clinical Therapeutics. 29:196-209
Published guidelines suggest the management of high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) values after the low-density lipoprotein cholesterol (LDL-C) goal is achieved.This study evaluated the attainment of optimal combined li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21817382aabf53d816e1664d4acbe202
https://doi.org/10.1016/j.clinthera.2007.01.004
https://doi.org/10.1016/j.clinthera.2007.01.004
Autor:
Scott L. Charland, Edward P. Armstrong
Publikováno v:
Current Medical Research and Opinion. 20:671-679
The objectives of this study were to: (1). determine the total hepatitis C virus (HCV)related and total healthcare costs (HCV plus other co-morbidities) of patients with HCV in a managed care organization; (2). determine total healthcare costs of HCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0160944ee4b9379798c531fe433d0bfb
https://doi.org/10.1185/030079904125003485
https://doi.org/10.1185/030079904125003485
Autor:
Eric J. Stanek, Scott L. Charland
Publikováno v:
Pharmacotherapy. 34(5)
Study Objectives To evaluate the relationship between low-density lipoprotein cholesterol (LDL-C) concentration and the annual incidence of combined coronary heart disease (CHD) events—death or nonfatal myocardial infarction (NFMI)—by using sigmo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a0af3aa11b108e3329d86ab8e448e09
https://pubmed.ncbi.nlm.nih.gov/24877185
https://pubmed.ncbi.nlm.nih.gov/24877185
Autor:
James J. Nawarskas, Eric G. Boyce, John E. Connors, Scott L. Charland, Sarah A. Spinler, Stanley Goldfarb
Publikováno v:
Annals of Pharmacotherapy. 32:1275-1283
OBJECTIVE:The predictive performance of 10 equations used to estimate creatinine clearance (Clcr) was assessed retrospectively from data collected on 420 patients.DESIGN:This study is a retrospective data analysis of information collected on hemodyna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12060def8b83f1a92abb2c6d58929344
https://doi.org/10.1345/aph.18122
https://doi.org/10.1345/aph.18122
Autor:
Dawn Ej Klinter, Scott L. Charland
Publikováno v:
Annals of Pharmacotherapy. 32:258-264
More than 621 patients diagnosed with a PE have been treated with LMWH. This review included five randomized clinical trials (> 433 patients treated with LMWH) comparing LMWH with UFH. The remainder of the clinical studies were dose-response trials,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374df424603ce6a696651f657f3b5643
https://doi.org/10.1345/aph.16474
https://doi.org/10.1345/aph.16474
Publikováno v:
Surgery. 118:87-97
Background. The tumor-bearing state is associated with increased circulating glucagon levels that may play an etiologic role in cancer cachexia. The secretion of glucagon can be inhibited with long-term somatostatin analogs, and, in combination with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f263aa70c3431f252eb8b9820ebf0250
https://doi.org/10.1016/s0039-6060(05)80014-5
https://doi.org/10.1016/s0039-6060(05)80014-5